e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Oncological problems, surgical risk and complications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The current value of mediastinoscopy in the diagnosis of non-lung cancer pathologies
S. Onat, R. Ulku, G. Ates, A. Avci, T. Yildiz, C. Ozcelik (Diyarbakir, Canakkale, Turkey)
Source:
Annual Congress 2010 - Oncological problems, surgical risk and complications
Session:
Oncological problems, surgical risk and complications
Session type:
Thematic Poster Session
Number:
2783
Disease area:
Interstitial lung diseases, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Onat, R. Ulku, G. Ates, A. Avci, T. Yildiz, C. Ozcelik (Diyarbakir, Canakkale, Turkey). The current value of mediastinoscopy in the diagnosis of non-lung cancer pathologies. Eur Respir J 2010; 36: Suppl. 54, 2783
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
The clinical value of autoflurescence bronchoscopy for precancerous lesions in operable primary lung cancer patients
Source: Annual Congress 2007 - Diagnostic bronchoscopy and transthoracic aspiration
Year: 2007
EBUS-TBNA
vs
mediastinoscopy for the staging of lung cancer
Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy
Year: 2006
The role of bronchoscopy in the diagnosis of lung cancer and other diseases
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0.
Source: International Congress 2019 – General thoracic surgery
Year: 2019
EBUS-TBNA in lung cancer staging
Source: Annual Congress 2008 - Ways into the mediastinum
Year: 2008
The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer
Source: Eur Respir J 2006; 28: 915-919
Year: 2006
EUS-FNA as the first diagnostic procedure in lung cancer staging
Source: Annual Congress 2009 - The ultrasound view
Year: 2009
The value of autofluorescence bronchoscopy in the pre-operative staging of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 525s
Year: 2004
Success of EBUS TBNA in centrally located lung tumours after non-diagnostic bronchoscopy in patients with suspected lung cancer
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007
Bronchoscopic techniques in diagnosis and staging of lung cancer
Source: Breathe 2011; 7: 324-337
Year: 2011
Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007
The value of other diagnostic techniques in patients with lung cancer that can not be diagnosed by fiberoptic bronchoscopy
Source: Eur Respir J 2004; 24: Suppl. 48, 299s
Year: 2004
Dealys in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004
Our diagnostic time for lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 322s
Year: 2005
N-staging in CT N
0
-N
1
non-small cell lung cancer patients: is there any place for mediastinoscopy?
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007
Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019
The efficacy of cytology sampling in the diagnosis of suspected endobronchial lung cancer
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006
Yield of real-time EBUS-TBNA in the diagnosis and staging of lung cancer
Source: Annual Congress 2005 - New techniques in diagnostic and therapeutic interventional pulmonology
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept